Dates:
Competition closes: 28 August 2024 2:00pm
Application open: 17 July 2024
Contracts start: January 2025
Scope
The aim of the open tender is to facilitate the development and validation of innovations which address a clearly articulated challenge faced by the NHS and/or the social care community and build on the value proposition required by commissioners and regulators for NHS adoption and wider commercialisation.
Specific Themes
The SBRI Healthcare Competition 25 Phase 1 funding competition invites breakthrough technologies to address challenges in Women’s Health and aims to identify innovative solutions which have the potential to enter the NHS, social care and the wider market, tackling: 1. Gynaecological Conditions and Hormonal Health 2. Mental Health 3. Chronic Conditions and Long-term Health
Projects that will not be funded
Any technologies that negatively impact staff workloads and do not support the workforce pressure, or those that require high upfront capital investment by clinical services (therefore negatively impacting on NHS affordability) will be excluded.
- Systems and solutions that will not easily integrate or communicate with NHS/community setting systems.
- Technologies that will exacerbate health inequalities (including digital exclusion or data inequalities) and inequity of access to care e.g., digital technologies that are inaccessible to certain communities that experience digital poverty.
- Solutions that were not co-designed with women
- Solutions which do not recognise nor address the intersectionality of health determinants, including socioeconomic status, race, and gender identity, in managing chronic conditions among women.
- Medicines.
Eligibility
- The competition is open to single organisations (contracts are executed with individual legal entities) based in the UK or EU from the private, public, and third sectors, including companies (large corporates and small and medium enterprises), charities, universities and NHS providers, as long as a strong commercial strategy is provided. Organisations based outside the UK or EU with innovations in remit for this call can apply as subcontractors of a lead UK/EU based organisation or via a UK or EU subsidiary.
- Collaborations are encouraged in the form of subcontracted services as appropriate.
Funding Rates
- Total eligible project costs: Phase 1 up to £100,000 (NET) and Phase 2 up to £800,000 (NET).
- Phase 1 Feasibility Studies: contracts for technical and commercial feasibility testing, duration 6 months
- Phase 2 contracts for prototype development and early clinical evidence, duration over 12 months, subject to budget availability.
How PNO can support you
The UK team has a strong track record in securing some of the most competitive national and European grants on behalf of its clients, with a full understanding of how a project should be presented to stand the highest chance of success. Each year in the UK alone, we are responsible for the submission of more than 100 funding applications across all sectors and priority areas. Based on this extensive experience, through careful project selection and using key insight into how a project should be best positioned, we consistently achieve success rates that are more than 5 times the typical success rates for UK national schemes and EU programmes.
